Jessica Boyd1,2, Alexander A Leung3, Hossein Sm Sadrzadeh1,2, Christina Pamporaki4, Karel Pacak5, Timo Deutschbein6, Stephanie Fliedner7, Gregory A Kline3. 1. Department of Clinical Pathology, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada. 2. Alberta Public Laboratory, Calgary, Alberta, Canada. 3. Department of Medicine/Endocrinology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada. 4. Department of Endocrinology, University Hospital, Carl Gustav Carus at TU Dresden, Dresden, Germany. 5. Section of Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA. 6. Division of Endocrinology and Diabetes, Department of Internal Medicine I, University Hospital Wuerzburg, University of Wuerzburg, Wuerzburg, Germany. 7. Neuroendocrine Oncology and Metabolism, First Department of Medicine, University Medical Center Schleswig-Holstein, Lübeck, Germany.
Abstract
OBJECTIVE: Determine rate of high plasma normetanephrine or metanephrine (PNM-PMN) in a large sample of patients according to PNM-PMN posture and age-adjusted references. DESIGN: Retrospective re-analysis of PNM-PMN from a Canadian reference laboratory (n = 5452), 2011-2015; most were in seated position (n = 5112) rather than supine (n = 340). An international PPGL database demonstrated expected distribution of supine PNM-PMN in PPGL patients. METHODS: All PNM-PMN from a tertiary referral laboratory were reviewed. Any PNM-PMN result greater than 2× upper reference limit (URL) was considered likely true PPGL. Results 1-2× URL were uncertain, requiring additional testing/follow-up despite most being false positive given the rarity of PPGL. The rate of results in the 1-2× URL category were calculated for each group according to collection posture and differing published URL: seated, supine or supine age adjusted. RESULTS: When collected and interpreted by seated URL, 19.6% of PNM required additional testing; only 4.6% being >2× URL. For patients over age 50 years, the abnormal rate was 24.9%. When collected supine, interpreted by supine age-adjusted URL, only 5.3% of PNM were mildly elevated. Possible false positives may be even lower when considering PMN or plasma methoxytyramine which were commonly high in true PPGL despite mild PNM elevations. CONCLUSIONS: In a general medical population, seated PNM has a high rate of abnormal results, far exceeding expected prevalence. Supine measurement with supine, age-adjusted interpretation is strongly preferred prior to costly or invasive PPGL investigations. SUMMARY: Review of 5452 plasma normetanephrine measurements showed 20% to be high, likely false positives for most. Supine, age-adjusted measures were half as likely to be elevated.
OBJECTIVE: Determine rate of high plasma normetanephrine or metanephrine (PNM-PMN) in a large sample of patients according to PNM-PMN posture and age-adjusted references. DESIGN: Retrospective re-analysis of PNM-PMN from a Canadian reference laboratory (n = 5452), 2011-2015; most were in seated position (n = 5112) rather than supine (n = 340). An international PPGL database demonstrated expected distribution of supine PNM-PMN in PPGL patients. METHODS: All PNM-PMN from a tertiary referral laboratory were reviewed. Any PNM-PMN result greater than 2× upper reference limit (URL) was considered likely true PPGL. Results 1-2× URL were uncertain, requiring additional testing/follow-up despite most being false positive given the rarity of PPGL. The rate of results in the 1-2× URL category were calculated for each group according to collection posture and differing published URL: seated, supine or supine age adjusted. RESULTS: When collected and interpreted by seated URL, 19.6% of PNM required additional testing; only 4.6% being >2× URL. For patients over age 50 years, the abnormal rate was 24.9%. When collected supine, interpreted by supine age-adjusted URL, only 5.3% of PNM were mildly elevated. Possible false positives may be even lower when considering PMN or plasma methoxytyramine which were commonly high in true PPGL despite mild PNM elevations. CONCLUSIONS: In a general medical population, seated PNM has a high rate of abnormal results, far exceeding expected prevalence. Supine measurement with supine, age-adjusted interpretation is strongly preferred prior to costly or invasive PPGL investigations. SUMMARY: Review of 5452 plasma normetanephrine measurements showed 20% to be high, likely false positives for most. Supine, age-adjusted measures were half as likely to be elevated.
Authors: Roland Därr; Matthias Kuhn; Christoph Bode; Stefan R Bornstein; Karel Pacak; Jacques W M Lenders; Graeme Eisenhofer Journal: Endocrine Date: 2017-04-12 Impact factor: 3.633
Authors: Graeme Eisenhofer; Aleksander Prejbisz; Mirko Peitzsch; Christina Pamporaki; Jimmy Masjkur; Natalie Rogowski-Lehmann; Katharina Langton; Elena Tsourdi; Mariola Pęczkowska; Stephanie Fliedner; Timo Deutschbein; Felix Megerle; Henri J L M Timmers; Richard Sinnott; Felix Beuschlein; Martin Fassnacht; Andrzej Januszewicz; Jacques W M Lenders Journal: Clin Chem Date: 2018-08-10 Impact factor: 8.327
Authors: Dirk Weismann; Mirko Peitzsch; Anna Raida; Aleksander Prejbisz; Maria Gosk; Anna Riester; Holger S Willenberg; Reiner Klemm; Georg Manz; Timo Deutschbein; Matthias Kroiss; Roland Därr; Martin Bidlingmaier; Andrzej Januszewicz; Graeme Eisenhofer; Martin Fassnacht Journal: Eur J Endocrinol Date: 2014-12-01 Impact factor: 6.664
Authors: Jacques W M Lenders; Quan-Yang Duh; Graeme Eisenhofer; Anne-Paule Gimenez-Roqueplo; Stefan K G Grebe; Mohammad Hassan Murad; Mitsuhide Naruse; Karel Pacak; William F Young Journal: J Clin Endocrinol Metab Date: 2014-06 Impact factor: 5.958